3,5-DIFLUORO-4-((8-METHOXY-2-OXO-4H-(1,3)OXAZINO(5,4-C)(1,8)NAPHTHYRIDIN-1-YL)METHYL)BENZENESULFONAMIDE
UNII FB6W6B6FRL
Substance Identification & Data
This profile provides standardized clinical and technical data for 3,5-difluoro-4-((8-methoxy-2-oxo-4h-(1,3)oxazino(5,4-c)(1,8)naphthyridin-1-yl)methyl)benzenesulfonamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FB6W6B6FRL.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2944114-41-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H14F2N4O5S ICSPRMNBEMULMT-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3,5-difluoro-4-((8-methoxy-2-oxo-4h-(1,3)oxazino(5,4-c)(1,8)naphthyridin-1-yl)methyl)benzenesulfonamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.